The recombinant therapeutic antibodies and proteins market comprises various antibody and peptide-based drugs that are produced through recombinant DNA technology. These biologics are widely used for treating conditions such as cancer, autoimmune diseases, and other chronic ailments. The market has witnessed significant growth over the past few years owing to rising prevalence of various...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian